We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-3.31%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$2.38B
AUM Growth
+$407M
Cap. Flow
+$540M
Cap. Flow %
22.68%
Top 10 Hldgs %
32.09%
Holding
169
New
35
Increased
72
Reduced
38
Closed
24

Top Sells

Rank Stock Value
1
COUR icon
Coursera
COUR
+$25.2M
2
APP icon
Applovin
APP
+$22.4M
3
CTSH icon
Cognizant
CTSH
+$20.7M
4
CPAY icon
Corpay
CPAY
+$19.5M
5
AKAM icon
Akamai
AKAM
+$18.1M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Communication Services 13.73%
3 Healthcare 12.21%
4 Consumer Discretionary 11.73%
5 Energy 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$235M 9.88%
+550,000
New +$245M
AAPL icon
2
Apple
AAPL
$4.99T
$85.6M 3.6%
+500,000
New +$91.7M
VTRS icon
3
Viatris
VTRS
$20.8B
$68.6M 2.88%
6,952,645
+1,388,362
+25% +$14.5M
C icon
4
Citigroup
C
$222B
$60M 2.52%
1,459,445
+862,628
+145% +$37.9M
BMY icon
5
Bristol-Myers Squibb
BMY
$130B
$56.2M 2.36%
968,234
+414,551
+75% +$25.4M
WEX icon
6
WEX
WEX
$6.23B
$53.7M 2.26%
285,523
-7,798
-3% -$1.51M
T icon
7
AT&T
T
$169B
$53.6M 2.25%
3,566,961
+683,870
+24% +$10M
SSNC icon
8
SS&C Technologies
SSNC
$18.8B
$50.9M 2.14%
968,715
+106,812
+12% +$6.11M
CLVT icon
9
Clarivate
CLVT
$1.53B
$50.2M 2.11%
7,486,244
+763,368
+11% +$6.09M
ZM icon
10
Zoom
ZM
$26.8B
$50M 2.1%
714,463
+127,504
+22% +$8.85M
VZ icon
11
Verizon
VZ
$201B
$48.8M 2.05%
1,505,478
+643,034
+75% +$21.7M
CMCSA icon
12
Comcast
CMCSA
$85.8B
$48.5M 2.04%
1,093,665
-37,810
-3% -$1.69M
CHRD icon
13
Chord Energy
CHRD
$7.25B
$45.4M 1.91%
280,135
+7,996
+3% +$1.25M
PENN icon
14
PENN Entertainment
PENN
$2.82B
$44.9M 1.89%
+1,958,246
New +$47.4M
EBAY icon
15
eBay
EBAY
$52.1B
$43.9M 1.85%
996,426
+93,358
+10% +$4.16M
CPAY icon
16
Corpay
CPAY
$25.1B
$43.5M 1.83%
170,198
-74,716
-31% -$19.5M
LYFT icon
17
Lyft
LYFT
$5.87B
$41.8M 1.76%
3,966,780
+334,440
+9% +$3.73M
EXPE icon
18
Expedia Group
EXPE
$35.5B
$41.1M 1.73%
398,570
+75,136
+23% +$8.29M
GOOG icon
19
Alphabet (Google) Class C
GOOG
$4.07T
$39.6M 1.66%
+300,000
New +$39M
ES icon
20
Eversource Energy
ES
$28.4B
$37.5M 1.57%
+644,133
New +$42.9M
WBD icon
21
Warner Bros
WBD
$64.2B
$31.2M 1.31%
2,875,792
+677,447
+31% +$8.46M
AEE icon
22
Ameren
AEE
$31.1B
$29.1M 1.22%
+388,686
New +$31.7M
FTDR icon
23
Frontdoor
FTDR
$5.22B
$29.1M 1.22%
949,706
-245,902
-21% -$8.15M
GPN icon
24
Global Payments
GPN
$23.9B
$29M 1.22%
251,571
+6,679
+3% +$795K
KGC icon
25
Kinross Gold
KGC
$28.1B
$25.3M 1.06%
5,553,440
+191,760
+4% +$940K

Similar funds

Invenomic Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Invenomic Capital Management held 169 positions worth $2.38B, up 21% from $1.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Invenomic Capital Management deployed $540M of net new capital in Q3 2023, opening 35 new positions and adding to 72 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 550,000 shares worth $235M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Applovin, an estimated $22.4M trimmed.

  • Invenomic Capital Management's largest Q3 2023 buy was State Street SPDR S&P 500 ETF Trust: 550,000 shares worth $235M.
  • Invenomic Capital Management added most to Citigroup in Q3 2023, an estimated $37.9M increase.
  • Invenomic Capital Management's biggest Q3 2023 reduction was Applovin, cutting an estimated $22.4M.
  • Invenomic Capital Management fully exited Coursera in Q3 2023, selling an estimated $25.2M.
  • Invenomic Capital Management's ten largest holdings make up 32% of its $2.38B portfolio in Q3 2023.
  • Invenomic Capital Management opened 35 new positions and closed 24 in Q3 2023.
  • Invenomic Capital Management's portfolio value rose 21% quarter-over-quarter to $2.38B.

Based on Invenomic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.